Submit Release
News Search

There were 2,384 press releases posted in the last 24 hours and 468,278 in the last 365 days.

EMEA-003032-PIP01-21-M01

P/0073/2023 : EMA decision of 10 March 2023 on the acceptance of a modification of an agreed paediatric investigation plan for ibutamoren mesylate (EMEA-003032-PIP01-21-M01)

AdoptedFirst published: Last updated:

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

EMEA-003032-PIP01-21-M01

Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.